No significant difference in severe UTIs was observed between patients starting SGLT-2 inhibitors for type 2 diabetes, compared to DPP-4 inhibitors or GLP-1 agonists. . . Summary: https://bit.ly/2YMxdoU
by 2minmed 5 years ago | via Instagram